5Clinical Laboratory Standard Institute. Performance standards for antimicrobial susceptibility testing [S]. M100-S19,2009.
6Clinical Laboratory crobial Dilution and Standard Institute Disk Susceptibility Methods for Antimi Testing of Infrequent ly Isolated or Fastidious Bacteria [S]. Approved Guideline M45-A, 2006, 26(19).
7Yang QW, Wang H, Sun HL, et al. Phenotypic and geno typic characterization of Enterobacteriaceae with decreased susceptibility to carbapenems: results from large hospital-based surveillance studies in China[J]. Antimicrob Agents Chemother,2010, 54(1): 573-577.
8Wang H, Guo P, Sun HL et al. Molecular epidemiology of clinical isolates of carbapenem resistant Acinetobacter spp from chinese hospitals[J]. Antimicrob Agents Chemother, 2007, 51(11): 4022-4028.
9Perez F, Hujer AM, Hujer KM et al. Global challenge of multidrug resistantAcinetobacterbaumannii[J]. Antimicrob Agents Chemother,2007,51(10) : 3471-3484.
10Boucher HW, Talbot G, Bradley JS, et al. Bad bugs, no drugs: No ESKAPE! An update from the IDSA[J]. Clin Infent Dis, 2009, 48(1):1-12.
